Literature DB >> 33416009

Neferine improves oxidative stress and apoptosis in benign prostate hyperplasia via Nrf2-ARE pathway.

Nabila Jahan1, Apu Chowdhury2, Ting Li1, Ke Xu1, Fen Wei1, Sicen Wang1.   

Abstract

BACKGROUND: Progression of Benign Prostate hyperplasia (BPH) is vulnerable to oxidative stress (OS) and prostatic enlargement among the aging males through apoptosis deregulation. Our present study aimed to investigate the effect of neferine (NF) in the regulation of oxidative stress and apoptosis in human BPH-1 cells.
METHODS: BPH epithelial cell line BPH-1 was treated with NF for 24 and 48 h. To measure oxidative stress (OS) we investigated MDA, SOD, and GST expression along with Nrf2 and its downstream gene and protein expression. Cell proliferation and apoptosis regulation was assayed with respective methods.
RESULTS: Investigation revealed NF remarkably activate Nrf2 and its downstream proteins HO-1 and NQO1 at 48 h more substantially. Nrf2/Keap1 relative gene and protein expression indicated that NF might trigger Nrf2 upregulation by decreasing Keap1 expression. Both NF concentrations (3 µM and 9 µM) were able to deplete ROS and lipid peroxidation, concurrently, up-regulated SOD and GST. NF reduced cell proliferation significantly along with the regulation of apoptotic proteins Bax, Bcl2, Cyt-C, Caspase 9, and Caspase 3 at the same time (48 h).
CONCLUSION: This study is the first to manifest that NF may potentially regulate BPH by counterbalancing between OS and apoptosis through the activation of Nrf2-ARE pathway.

Entities:  

Keywords:  BPH; Bax; Bcl-2; Keap1; Neferine; Nrf2; apoptosis; oxidative stress

Mesh:

Substances:

Year:  2021        PMID: 33416009      PMCID: PMC7808392          DOI: 10.1080/13510002.2021.1871814

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  50 in total

Review 1.  The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

Authors:  Joanne Smith; Lye Mun Tho; Naihan Xu; David A Gillespie
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

Review 2.  Regulation of Nrf2-an update.

Authors:  Suryakant K Niture; Raju Khatri; Anil K Jaiswal
Journal:  Free Radic Biol Med       Date:  2013-02-19       Impact factor: 7.376

3.  Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.

Authors:  Melinda C Myzak; Karin Hardin; Rong Wang; Roderick H Dashwood; Emily Ho
Journal:  Carcinogenesis       Date:  2005-11-09       Impact factor: 4.944

4.  Bisbenzylisoquinoline Alkaloids from Nelumbo nucifera.

Authors:  Atsuko Itoh; Tomomi Saitoh; Kaori Tani; Misaki Uchigaki; Yumi Sugimoto; Jun Yamada; Hiroshi Nakajima; Hideo Ohshiro; Schujian Sun; Takao Tanahashi
Journal:  Chem Pharm Bull (Tokyo)       Date:  2011       Impact factor: 1.645

5.  Androgen excess produces systemic oxidative stress and predisposes to beta-cell failure in female mice.

Authors:  Suhuan Liu; Guadalupe Navarro; Franck Mauvais-Jarvis
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

6.  p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer.

Authors:  H Schlechte; S V Lenk; T Löning; D Schnorr; B D Rudolph; G Ditscherlein; S A Loening
Journal:  Eur Urol       Date:  1998       Impact factor: 20.096

7.  High animal fat intake enhances prostate cancer progression and reduces glutathione peroxidase 3 expression in early stages of TRAMP mice.

Authors:  Seo-Na Chang; Juhee Han; Tamer Said Abdelkader; Tae-Hyoun Kim; Ji Min Lee; Juha Song; Kyung-Sul Kim; Jong-Hwan Park; Jae-Hak Park
Journal:  Prostate       Date:  2014-07-22       Impact factor: 4.104

Review 8.  Oxidative Stress and Cancer: The Role of Nrf2.

Authors:  Soraya Sajadimajd; Mozafar Khazaei
Journal:  Curr Cancer Drug Targets       Date:  2018       Impact factor: 3.428

Review 9.  Prostate growth and inflammation.

Authors:  Alessandro Sciarra; Gianna Mariotti; Stefano Salciccia; Ana Autran Gomez; Salvatore Monti; Vincenzo Toscano; Franco Di Silverio
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-07       Impact factor: 4.292

10.  Anti-inflammatory effects of neferine on LPS-induced human endothelium via MAPK, and NF-κβ pathways.

Authors:  Deng Guolan; Wang Lingli; He Wenyi; Zhou Wei; Chen Baowei; Bing Sen
Journal:  Pharmazie       Date:  2018-09-01       Impact factor: 1.267

View more
  6 in total

1.  Association Between NOX4 And Nrf2 Genes in Non-Small-Cell Lung Carcinoma: A Case-Control Study.

Authors:  Nasim Bakhtiyari; Akbar Sharifi; Younes Aftabi; Neda Gilani; Venus Zafari; Atefeh Ansarin; Ensiyeh Seyedrezazadeh
Journal:  Rep Biochem Mol Biol       Date:  2021-07

2.  The Prostate-Associated Gene 4 (PAGE4) Could Play a Role in the Development of Benign Prostatic Hyperplasia under Oxidative Stress.

Authors:  Yan Li; Jianmin Liu; Daoquan Liu; Zhen Wang; Yongying Zhou; Shu Yang; Feng Guo; Liang Yang; Xinhua Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-05-19       Impact factor: 7.310

3.  Standardization of the ethanolic extract of Crinum latifolium leaves by two bioactive markers with antiproliferative activity against TGF-β-promoted prostate stromal cells (WPMY-1).

Authors:  Wisuwat Thongphichai; Tamonwan Uttarawichien; Pithi Chanvorachote; Supaporn Pitiporn; Todsaphol Charoen-Ame; Pakakrong Kwankhao; Pasarapa Towiwat; Suchada Sukrong
Journal:  BMC Complement Med Ther       Date:  2022-05-18

4.  Neferine Exerts Ferroptosis-Inducing Effect and Antitumor Effect on Thyroid Cancer through Nrf2/HO-1/NQO1 Inhibition.

Authors:  Shujing Li; Yanyan Zhang; Jin Zhang; Bo Yu; Weiran Wang; Baosong Jia; Jingtao Chang; Jing Liu
Journal:  J Oncol       Date:  2022-06-27       Impact factor: 4.501

5.  Therapeutic Effects of 25-Hydroxyvitamin D on the Pathological Process of Benign Prostatic Hyperplasia: An In Vitro Evidence.

Authors:  Yanbo Chen; Hui Xu; Chong Liu; Meng Gu; Qi Chen; Ming Zhan; Zhong Wang
Journal:  Dis Markers       Date:  2021-10-11       Impact factor: 3.434

Review 6.  The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective.

Authors:  Teow J Phua
Journal:  Medicines (Basel)       Date:  2021-06-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.